Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation - Wikidata - thesis-toulmin - TriplyDB

Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation

Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation

http://www.wikidata.org/entity/Q27666816

about

CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis Principles of antibody-mediated TNF receptor activation Dimerization of LT R by LT 1 2 is necessary and sufficient for signal transduction CD40L and Its Receptors in Atherothrombosis-An Update Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?Functional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 molecules Agonist antibodies to TNFR molecules that costimulate T and NK cells TNF superfamily protein-protein interactions: feasibility of small- molecule modulation Binding efficiency of protein-protein complexes.CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells Cysteine-rich domain 1 of CD40 mediates receptor self-assembly Human and mouse CD137 have predominantly different binding CRDs to their respective ligands Regulation of NF-κB by TNF family cytokines.Interaction of CD154 with different receptors and its role in bidirectional signals.CD154 is released from T-cells by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) and ADAM17 in a CD40 protein-dependent manner.Crystal structure of CD27 in complex with a neutralizing noncompeting antibody.Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.Structural principles of tumor necrosis factor superfamily signaling.Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling.Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab

P2860

Q21285053-4F70A061-E909-405A-B899-F796240CFB96 Q26796270-24FD74E0-EE5B-45F2-89FF-59A9220BD53D Q27680632-B69F9326-6B83-482A-8E2D-70FCDC5DFEC0 Q33814059-D7D9B59C-B26A-42A4-BC4C-05C656F79454 Q34262443-249915D6-A038-4D1C-967A-03CD0B810356 Q34637068-630E33D8-A008-4CB9-B3E5-CA3F4750372D Q35427446-3A4DE385-CB05-4B71-87D3-A12C8445007D Q35534271-E556A23D-3B8D-46DF-8AB2-FAF64BB2036A Q36595042-433AE97A-CEE4-4EEE-A678-016A0B287D8E Q36601966-2363B11A-7CE0-41DA-9EDF-64862BBB5121 Q36760450-B36E43E8-F23F-41A8-8FC1-3C74B53D138A Q37500368-22044D96-5243-428B-8E83-7FE035255EE0 Q38222709-D6BED584-C25E-4456-9E7E-49040CB931F7 Q38939816-502EB609-8C60-4E48-A2BA-EFDF750A7AB7 Q39067245-46B365CE-0062-4E1E-AFD5-A6B51C608513 Q42289647-6F6668DF-D0DE-4FEB-9EAD-E6F7174C6ED8 Q47292379-24743054-7979-47C3-B1A4-8BBA55D22377 Q47661976-29A2E208-47FB-46D9-8AEF-C422D642F8AD Q48319204-973C1B0B-1790-4370-AD82-F20CE64CACE9 Q50001718-0920A36A-6B83-4FDF-850B-778E4EA3344F Q58586476-58B12379-D31B-4C4C-8ED9-6BF21C53D2D1

P2860

Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation

http://www.wikidata.org/entity/Q27666816

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Crystallographic and Mutationa ...... ations for Receptor Activation

@ast

Crystallographic and Mutationa ...... ations for Receptor Activation

@en

Crystallographic and Mutationa ...... ations for Receptor Activation

@nl

type

label

Crystallographic and Mutationa ...... ations for Receptor Activation

@ast

Crystallographic and Mutationa ...... ations for Receptor Activation

@en

Crystallographic and Mutationa ...... ations for Receptor Activation

@nl

prefLabel

Crystallographic and Mutationa ...... ations for Receptor Activation

@ast

Crystallographic and Mutationa ...... ations for Receptor Activation

@en

Crystallographic and Mutationa ...... ations for Receptor Activation

@nl

P1433

Q27666816-B13F6EEC-1489-47BE-9E64-36FB7ED7D67F

P1476

Q27666816-A21BA818-6B9B-4094-8548-4A4472E9C7B0

P2093

Q27666816-356AFBD9-44C5-4C99-B932-4590EC837A16

Q27666816-5AEB34E6-18F8-4148-A4DB-75A25BD2793E

Q27666816-73B2841B-83AC-4E42-A614-4DAC61DCF516

Q27666816-96CA9329-E0BE-4B3C-8022-0A49F212AFB3

Q27666816-BA9FA817-4035-43E6-82A3-9E9C7F867B87

Q27666816-BD72F7A9-138A-465C-9D3B-F7C24CAD03AD

Q27666816-F476F8D8-5E13-472D-9748-7861ACA953D2

Q27666816-F4B0FBF4-5318-4680-8B0C-B5AAFFD6E892

Q27666816-FEF4004C-95EF-460F-B7F6-32ADEB912A08

P2860

Q27666816-0049E7A7-07E9-4BC3-ADBD-4E8BC9CDEF66

Q27666816-00BDF57A-49D2-461B-8913-0B13C404BFE0

Q27666816-0723F1B3-B4C1-4F12-9A45-1F55E669B517

Q27666816-0D51CB88-70CA-46E2-98F7-597E141D6538

Q27666816-1B8DA371-50C1-4ABC-807F-9106A0A8A9FD

Q27666816-2660F7D0-347C-4E3B-A969-21A0C000FAA3

Q27666816-29293DDC-34A9-4A73-8B98-D72673C2DFD6

Q27666816-2AF16DD6-EB1B-4106-9029-4A01EDA7D8C7

Q27666816-356D3C0A-5F2B-4A64-847E-7A2355C36AF0

Q27666816-35821D1D-F4B0-41E3-9321-EBA1137219D0

P304

Q27666816-8A376A38-1912-4469-99E4-BA118EB6A973

P31

Q27666816-274CF3F2-1CF2-4A48-94F6-6A5A6856EC0C

P356

Q27666816-1C02DCB8-6893-4260-9337-2B1777BEE2C2

P407

Q27666816-E8F8F55A-5294-4720-8BD1-8146AB311D34

P433

Q27666816-FDA23A22-F8FD-42DD-94FA-2520383F67BD

P478

Q27666816-75272851-353B-4D67-A0ED-DC49811338BF

P577

Q27666816-0E98EDB4-112F-4C05-A58D-DC72CE0AD832

P698

Q27666816-A3727B64-8DCA-4DBE-A6D4-16CEA8421A46

P921

Q27666816-0D1438F3-B216-4F3F-AB2B-C21215DB4954

P932

Q27666816-44F0D114-D3E3-4B3D-8098-3D8519B3293C

P356

JBC.M110.208215

P1433

Journal of Biological Chemistry

P1476

Crystallographic and Mutationa ...... ations for Receptor Activation

@en

P2093

Beom Suk Park

http://www.w3.org/2001/XMLSchema#string

Dong Hyun Song

http://www.w3.org/2001/XMLSchema#string

Hayyoung Lee

http://www.w3.org/2001/XMLSchema#string

Ho Min Kim

http://www.w3.org/2001/XMLSchema#string

Hyun-Jung An

http://www.w3.org/2001/XMLSchema#string

Jie-Oh Lee

http://www.w3.org/2001/XMLSchema#string

Ju Dong Lee

http://www.w3.org/2001/XMLSchema#string

Sang-Gi Paik

http://www.w3.org/2001/XMLSchema#string

Young Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations

The Fas-FADD death domain complex structure unravels signalling by receptor clustering

Knowledge-based model building of proteins: concepts and examples

Improved methods for building protein models in electron density maps and the location of errors in these models

Structural basis for self-association and receptor recognition of human TRAF2

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation

Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody

Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation

Ligand-receptor binding revealed by the TNF family member TALL-1

P304

11226-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.208215

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21285457

http://www.w3.org/2001/XMLSchema#string

P921

P932

3064178

http://www.w3.org/2001/XMLSchema#string